Skip to main content
Completed Clinical Trials

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

By April 24, 2017No Comments

Condition

Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer

Estimated Enrollment: null

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: CDR0000067228|NCI-99-C-0129|NCI-T99-0012

Study First Received: July 11, 2001

Last Updated: April 28, 2015

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

Sponsors and Collaborators:

National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00019825

Leave a Reply